Patrick Hanley

Associate Professor

George Washington University

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

LinkedIn

Google Scholar

About

Patrick Hanley is an Associate Professor at George Washington University, USA. His research focuses on immunotherapy, specifically in the areas of cell and gene therapy, HIV-specific T cell therapy, and the safety and efficacy of tumor-associated antigen-specific T cells. He has contributed to various studies on the application of flow cytometry in therapeutic settings and the manufacturing practices of cellular therapy products.

Articles (13)

Autologous HIV-specific T cell therapy targeting conserved epitopes is well-tolerated in six adults with HIV: an open-label, single-arm phase 1 study

Year:

2025

Review of flow cytometry as a tool for cell and gene therapy

Year:

2024

Environmental monitoring of current good manufacturing practices cleanroom facilities for manufacturing of cellular therapy products in an academic hospital setting

Year:

2024

Emerging frontiers in immuno- and gene therapy for cancer

Year:

2023

Tumor-associated antigen-specific T cells with nivolumab are safe and persist in vivo in relapsed/refractory Hodgkin lymphoma

Year:

2022

Delivering externally manufactured cell and gene therapy products to patients: perspectives from the academic center experience

Year:

2022

ISCT survey on hospital practices to support externally manufactured investigational cell-gene therapy products

Year:

2022

Virus-specific T cells for adenovirus infection after stem cell transplantation are highly effective and class II HLA restricted.

Year:

2021

Flow-based analysis of cell division identifies highly active populations within plasma products during mixed lymphocyte cultures.

Year:

2021

Identification of novel HLA-restricted preferentially expressed antigen in melanoma peptides to facilitate off-the-shelf tumor-associated antigen-specific T-cell therapies.

Year:

2021

Influence of administration of mesenchymal stromal cell on pediatric oxygenator performance and inflammatory response.

Year:

2021

SARS-CoV-2-specific T cells are rapidly expanded for therapeutic use and target conserved regions of the membrane protein.

Year:

2020

Processing laboratory considerations for multi-center cellular therapy clinical trials: a report from the Consortium for Pediatric Cellular Immunotherapy.

Year:

2020

Collaborators (5)

Christopher Lazarski

Assistant Professor

George Washington University

UNITED STATES

Michael Keller

Assistant Professor

George Washington University

UNITED STATES

John Ligon

Assistant Professor

University of Florida

UNITED STATES

Catherine M. Bollard

Director/Professor

-

UNITED STATES

Jeremy Rubinstein

Assistant Professor

Cincinnati Children's Hospital Medical Center

UNITED STATES

Social connections

How do I reach out?

Sign in for free to see their profile details and contact information.

Meet Kite AI